Guido Oelkers, CEO of listed biopharma Swedish Orphan Biovitrum (Sobi), is stepping down from his current role to take up another position outside Sobi. He will remain in-post until the end January 2027 at the latest.
Sobi has begun the process of identifying a successor.
Oelkers joined Sobi in 2017.
Sobi has...
Nico Brezan has been appointed as the new CEO at RanD Spa, an Italian medical device company and a portfolio company of Switzerland-based investor Continental Investment Partners.
Founded in 1999, RanD is a medical device company specialising in surgical oncology, Hyperthermic Intraperitoneal Chemotherapy, perfusion science, and advanced biomedical technologies. Brezan brings extensive international experience in the medical device sector, with particular expertise in distributor network development, international commercial partnerships, and new market development.
Prior to RanD, he spent 17 years at UK-based Corin Group, a producer of orthopaedic products. He has also...